Q1 2022 Singular Genomics Systems Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Singular Genomics' First Quarter 2022 Earnings Conference Call. (Operator Instructions)
It is now my pleasure to turn the floor over to your host, [Philip Taylor]. Sir, the floor is yours.
Thank you, operator. Presenting today are Singular Genomics' Founder and Chief Executive Officer, Drew Spaventa; and Head of Finance, Dalen Meeter. Earlier today, Singular Genomics released financial results for the 3 months ended March 31, 2021. A copy of the press release is available on the company's website.
Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's view as of today, May 10, 2022, only and will include forward-looking statements and opinion statements including predictions, estimates, plans, expectations and other information.
Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |